403
Sorry!!
Error! We're sorry, but the page you were
looking for doesn't exist.
Comprehensive Metabolic Panel Testing Market Size To Hit USD 24.48 Billion By 2032, Growing At 9.12% CAGR – SNS Insider
| Report Attributes | Details |
| Market Size in 2023 | US$ 11.18 billion |
| Market Size by 2032 | US$ 24.48 billion |
| CAGR | CAGR of 9.12% From 2024 to 2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020-2022 |
| Key Regional Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East]), Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia Rest of Latin America) |
Segment Analysis
By Analytes
The glucose segment accounted for the largest share of 13.2% in 2023 owing to increase in global diabetes cases along with the universal adoption of glucose testing for routine health checks and critical care monitoring. The CMP panel also involves glucose which is an important biomarker and a first-line marker of metabolic dysfunction. Increased diabetes screening by governments and NGOs including India's nationwide diabetes awareness initiative and the American Diabetes Association's annual alert day are increasing volumes of glucose testing. Many insurance-covered wellness programs also require fasting glucose levels. Demand for continuous glucose monitoring and HbA1c testing also indirectly increases the relevance of glucose in CMP tests.
By Disease
Kidney disease accounted for the largest market share in 2023, at 32.8%. The growing burden of chronic kidney disease (CKD), especially in aging populations, has increased reliance on CMP testing for early diagnosis and monitoring. CMP panels help assess kidney function through serum creatinine, blood urea nitrogen (BUN), and electrolyte levels. According to the National Kidney Foundation, over 37 million adults in the U.S. have CKD, and millions more are at risk. CMP testing allows early identification of asymptomatic kidney damage, improving outcomes through timely treatment. Hospitals and nephrology centers are increasingly incorporating CMP tests into routine renal function screenings.
By End-Use
In 2023, the laboratory segment dominated the market and accounted for 60.1% of total revenue. Laboratories are seen as being favoured due to the integral part that high-throughput labs perform in routine health screening, corporate wellness programming, and diagnostic testing. CMP panels are often bundled with other tests such as CBC and lipid panels, making them cost-effective when processed through large labs. Major players, including Labcorp, Quest Diagnostics, and Eurofins, offer comprehensive CMP testing services globally, backed by advanced infrastructure and automated systems. Additionally, expanding partnerships between diagnostics labs and telehealth providers are making home collection kits for CMP testing readily available.
Need Any Customization Research on Comprehensive Metabolic Panel Testing Market, Enquire Now@
Comprehensive Metabolic Panel Testing Market Segmentation
By Analytes
- K+ Na+ Cl- CO2 Glucose BUN Creatinine Ca++ Albumin Total Protein ALP ALT AST Total Bilirubin
By Disease
- Kidney Diseases Liver Diseases Diabetes Others
By End-Use
- Laboratories
- Emergency Departments Hospital Wards Primary Care Pharmacy Telemedicine
- Emergency Departments Hospital Wards Primary Care Pharmacy Telemedicine
- Piccolo Xpress Skyla-HB1 DRI-CHEM NX500 Others
Regional Analysis
North America held the largest share of the global Comprehensive Metabolic Panel Testing Market in 2023, accounting for 46.2% of total revenue, owing to the presence of well-established healthcare infrastructure, high adherence to screening protocols, and favourable reimbursement policies. Increasing emphasis on chronic disease management along with wide coverage of metabolic testing by insurance promotes the expansion of the market. In addition, the presence of large diagnostic companies and the increase in the adoption of EHR-integrated laboratory systems boost the growth of the region. Europe follows closely with the widespread adoption of CMP testing in preventive care, with high adoption of such testing in Germany, the U.K., and France through national health programs targeting screening for metabolic diseases.
Asia-Pacific is expected to exhibit the fastest growth rate over the forecast period. Gaps in key pharmacoeconomic statistics, focused drug development toward the treatment of rare diseases, and government-based screening programs are driving growth in CMP tests. Urban middle-class population and rising concierge health checkup packages also continue to propel growth.
Recent Developments
- In November 2023, Labcorp introduced a new high-throughput chemistry analyzer capable of processing over 1,000 CMP tests per hour, targeting mass-screening initiatives in the U.S. In February 2024, partnered with CVS Health to expand CMP testing availability through retail health clinics across 35 states.
Table of Contents – Major Key Points
1. Introduction
2. Executive Summary
3. Research Methodology
4. Market Dynamics Impact Analysis
5. Statistical Insights and Trends Reporting
5.1 Incidence & Prevalence of Metabolic and Chronic Disorders (2023), by Region
5.2 Technological Advancements & Automation Adoption (2023-2032)
5.3 At-Home & Direct-to-Consumer (DTC) CMP Testing Trends
5.4 Regulatory & Policy Impact on CMP Testing Market (2023-2032)
5.5 Impact of AI and Machine Learning on CMP Testing
5.6 Price Trends & Cost Analysis of CMP Tests (2023), by Region
6. Competitive Landscape
7. Comprehensive Metabolic Panel Testing Market by Analytes
8. Comprehensive Metabolic Panel Testing Market by Disease
9. Comprehensive Metabolic Panel Testing Market by End-Use
10. Regional Analysis
11. Company Profiles
12. Use Cases and Best Practices
13. Conclusion
Related Reports
Blood Testing Market – Global Forecast 2024–2032
Clinical Laboratory Services Market – Growth & Trends Report 2024–2032
Point-of-Care Diagnostics Market Analysis 2024–2032
In Vitro Diagnostics (IVD) Market Outlook 2024–2032
Remote Patient Monitoring Report 2024–2032
About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.
CONTACT: Contact Us: Jagney Dave - Vice President of Client Engagement Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK)
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.
Most popular stories
More Story
Comments
No comment